Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gadebusch

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Antimicrobial Agents and Chemotherapy|March 1, 1988
Antibacterial activities of fluorovinyl- and chlorovinylglycine and several derived dipeptidesA A Patchett, D Taub, B Weissberger, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1977
Human serum protein binding of cephalosporin antibiotics in vitroS M Singhvi, A F Heald, H H Gadebusch, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1987
Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agentsD L Shungu, D R Nalin, R H Gilman, et al.
The Journal of Antibiotics|May 1, 1989
L-658,310, a new injectable cephalosporin. I. In vitro antibacterial propertiesB A Weissberger, G K Abruzzo, R A Fromtling, et al.
The Journal of Antibiotics|May 1, 1989
L-658,310, a new injectable cephalosporin. III. Experimental chemotherapeutics and pharmacokinetics in laboratory animalsE C Gilfillan, B A Pelak, B A Weissberger, et al.
Journal of Medicinal Chemistry|September 1, 1988
Phosphinic acid inhibitors of D-alanyl-D-alanine ligaseW H Parsons, A A Patchett, H G Bull, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Antimicrobial Agents and Chemotherapy|March 1, 1988
Antibacterial activities of fluorovinyl- and chlorovinylglycine and several derived dipeptidesA A Patchett, D Taub, B Weissberger, et al.
The Journal of Laboratory and Clinical Medicine|February 1, 1977
Human serum protein binding of cephalosporin antibiotics in vitroS M Singhvi, A F Heald, H H Gadebusch, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1987
Comparative susceptibilities of Campylobacter pylori to norfloxacin and other agentsD L Shungu, D R Nalin, R H Gilman, et al.
The Journal of Antibiotics|May 1, 1989
L-658,310, a new injectable cephalosporin. I. In vitro antibacterial propertiesB A Weissberger, G K Abruzzo, R A Fromtling, et al.
The Journal of Antibiotics|May 1, 1989
L-658,310, a new injectable cephalosporin. III. Experimental chemotherapeutics and pharmacokinetics in laboratory animalsE C Gilfillan, B A Pelak, B A Weissberger, et al.
Journal of Medicinal Chemistry|September 1, 1988
Phosphinic acid inhibitors of D-alanyl-D-alanine ligaseW H Parsons, A A Patchett, H G Bull, et al.
Pageof 5